IUdR/BUdR Cell Cycle Labelling

Completed · Not applicable

Conditions studied: Hematologic Malignancies

In brief

To determine cell cycle parameters and changes after treatment, the labelling agent is given and a bone marrow aspiration is accomplished before treatment and after treatment for comparison. Participants must be undergoing concurrent therapy for hematologic malignancy.

Key facts

Study ID

NCT00042250

Run by

M.D. Anderson Cancer Center

People needed

28

Starts

1992-05-01

Expected to finish

2002-10-01

Last updated by the study team

2012-01-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• M.D. Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.